Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase B-Raf (BRAF) is a serine/threonine-protein kinase that plays a central role in the RAS/RAF/MEK/ERK signaling pathway. This pathway transmits signals from cell surface receptors to the nucleus, regulating key cellular processes such as proliferation, differentiation, migration, and apoptosis. Mutations in BRAF, particularly V600E, are implicated in several cancers, making it an important therapeutic target. Several small-molecule inhibitors have been developed targeting mutant forms of B-Raf.
Inhibition of BRAF kinase activity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase B-Raf (BRAF).